Ventria Bioscience supports the Biotechnology Industry Organization (BIO) in developing standards for plant-made pharmaceuticals
Outcrossing plants reproduce by wind or insect pollination. In contrast, plant-made pharmaceuticals and industrials can also be produced using self-pollinating plants such as soybeans, rice and barley. These self-pollinating plants do not require the wind or insects for pollination.
"The use of plant systems to produce biopharmaceutical proteins and peptides is an important technology in the fight against human disease and it is quite appropriate that BIO take a leadership role in defining the standards for plant-made pharmaceutical production," said William J. Rutter, Ph.D., Ventria Board Member.
"Ventria's ExpressTec(TM) system is an ideal solution for the production of plant-made pharmaceuticals and industrials because it utilizes self-pollinating plants to produce biopharmaceuticals," said Scott Deeter, President & CEO, Ventria Bioscience.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.